Join
Live feed
·
INSIDERFilingvia Quantisnow
Relay Therapeutics Inc. logo

Chief Financial Officer Catinazzo Thomas sold $3,176,865 worth of shares (187,163 units at $16.97) as part of a pre-agreed trading plan and exercised 169,446 shares at a strike of $4.93, decreasing direct ownership by 9% to 177,461 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
RLAY· Relay Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RLAY (Relay Therapeutics Inc.) and more on Quantisnow.

Chief Financial Officer Catinazzo Thomas sold $3,176,865 worth of shares (187,163 units at $16.97) as part of a pre-agreed trading plan and exercised 169,446 shares at a strike of $4.93, decreasing direct ownership by 9% to 177,461 units (SEC Form 4) | Quantisnow